Rice Lynsey, Goldsmith Christy, Green Melanie Ml, Cleator Susan, Price Patricia M
Department of Radiation Oncology, The Harley Street Clinic.
Department of Surgery and Cancer, Imperial College London, London, UK.
Breast Cancer (Dove Med Press). 2017 Jun 14;9:437-446. doi: 10.2147/BCTT.S130090. eCollection 2017.
We developed, applied, and prospectively evaluated a novel deep-inspiration breath-hold (DIBH) screening and delivery technique to optimize cardiac sparing in left-breast radiotherapy (RT) at our clinic. The impact of set-up and dose variables upon organs at risk (OAR) dose in DIBH RT was investigated.
All patients with left-breast cancer referred between 2011 and 2014 - of all disease stages, set-up variations, and dose prescriptions - were included. Radiographers used simple screening criteria at CT simulation, to systematically assess patients for obvious DIBH benefit and capability. Selected patients received forward-planned intensity-modulated RT (IMRT) based on a DIBH CT scan. A 3D-surface monitoring system with visual feedback assured reproducible DIBH positioning during gated radiation delivery. Patient, target set-up, and OAR dose information were collected at treatment.
Of 272 patients who were screened, 4 withdrew, 56 showed no obvious advantage, and 56 showed benefit but had suitability issues; 156 patients were selected and successfully completed DIBH treatment. The technique was compatible with complex set-up and optimal target coverage was maintained. Comparison of free-breathing (FB) and DIBH treatment plans in the first five patients enrolled confirmed DIBH reduced heart radiation by ~80% ( = 0.032). Low OAR doses were achieved overall: the mean (95% confidence interval [CI]) heart dose was 1.17 (1.12-1.22) Gy, and the mean ipsilateral lung dose was 5.26 (5.01-5.52) Gy. Patients who underwent a standard radiation schedule (40 Gy/15#) after breast-conserving surgery had the lowest OAR doses: post-mastectomy treatment, simultaneous supraclavicular (SCV) node coverage, and alternative dose schedule (50 Gy/25#) were interrelated variables associated with increased OAR risk and compromised ipsilateral lung dose constraints.
The DIBH technique was successfully implemented and resulted in optimally low heart radiation. All patients who demonstrate sufficient DIBH technique at planning CT are now offered DIBH RT at our clinic. Patients with more advanced disease, particularly those with additional pulmonary risk factors, warrant additional focus to improve lung sparing.
我们研发、应用并前瞻性评估了一种新型深吸气屏气(DIBH)筛查与放疗技术,以优化我院左乳放疗(RT)中的心脏保护。研究了DIBH放疗中摆位和剂量变量对危及器官(OAR)剂量的影响。
纳入2011年至2014年间转诊的所有疾病分期、摆位变化和剂量处方的左乳癌患者。放射技师在CT模拟时使用简单的筛查标准,系统评估患者是否明显受益于DIBH及其实施能力。选定的患者基于DIBH CT扫描接受正向计划调强放疗(IMRT)。带有视觉反馈的三维表面监测系统确保在门控放疗期间DIBH摆位可重复。在治疗时收集患者、靶区摆位和OAR剂量信息。
在272例接受筛查的患者中,4例退出,56例未显示明显优势,56例显示受益但存在适用性问题;156例患者被选中并成功完成DIBH治疗。该技术与复杂摆位兼容,并维持了最佳靶区覆盖。对入组的前5例患者的自由呼吸(FB)和DIBH治疗计划进行比较,证实DIBH可使心脏受照剂量降低约80%(P = 0.032)。总体上实现了较低的OAR剂量:心脏平均(95%置信区间[CI])剂量为1.17(1.12 - 1.22)Gy,同侧肺平均剂量为5.26(5.01 - 5.52)Gy。保乳手术后接受标准放疗方案(40 Gy/15次)的患者OAR剂量最低:乳房切除术后治疗、同时锁骨上(SCV)淋巴结照射和替代剂量方案(50 Gy/25次)是与OAR风险增加和同侧肺剂量限制受损相关的相互关联变量。
DIBH技术成功实施,心脏受照剂量达到最佳低值。目前我院对所有在计划CT时显示有足够DIBH技术的患者提供DIBH放疗。疾病进展较严重的患者,尤其是那些有额外肺部危险因素的患者,需要额外关注以改善肺保护。